For the construction of pathologic tear models, we applied a simplified formula of tears according to a previous work with slight modification.
51 SSTs were compared with human tears and are briefly summarized in
Table 1. Because lipocalin is not a commercially available product,
52 only lactoferrin and lysozyme were used as backbone proteins in SSTs. The activity of these two tear proteins may be representative responses of tears to different ocular surface diseases and may be potential indicators of them.
53 –58 In brief, we used sterile deionized water to prepare all the stock solutions for the different SST concentrations. The stock solutions included 20 mg/mL lactoferrin, 20 mg/mL lysozyme, 26 mg/mL albumin, 6 mg/mL IgA, 12 mg/mL urea, and 42 mg/mL sodium bicarbonate. Taking SST3.0 as an example, we mixed 150 μL lactoferrin and 150 μL lysozyme with 50 μL other stock solutions and added 500 μL sterile deionized water. SSTs were mixed with reference strains
Pseudomonas aeruginosa ATCC 27853 and
Staphylococcus aureus ATCC 14957, which were used as infectious model tears. In brief, we mixed 150 μL lactoferrin and 150 μL lysozyme with 50 μL other stock solutions as described to create the stock synthetic tears. After obtaining fresh bacterial growth on a solid medium (approximately 3 days after inoculation), we vortexed the bacterial suspensions to break up any clumps and create a homogenous bacterial solution. The 2 × 10
9 cfu/mL bacterial suspensions were prepared using sterile deionized water according to the McFarland standard using a turbidity meter. Finally, we mixed the 2 × 10
9 cfu/mL bacterial suspensions and the stock synthetic tears in a ratio of 1:1. The infectious model tears were incubated for approximately 20 minutes at 36.5°C before Raman acquisition was performed.